HospiMedica

Download Mobile App
Recent News AI Critical Care Surgical Techniques Patient Care Health IT Point of Care Business Focus

ZOLL Showcases Expanded Portfolio of Products at Arab Health 2017

By HospiMedica International staff writers
Posted on 30 Jan 2017
Image: ZOLL Medical displayed an expanded portfolio of resuscitation and critical care products and technologies at Arab Health 2017 (Photo courtesy of ZOLL Medical).
Image: ZOLL Medical displayed an expanded portfolio of resuscitation and critical care products and technologies at Arab Health 2017 (Photo courtesy of ZOLL Medical).
ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, displayed its expanded and fully integrated portfolio of resuscitation and acute critical care technologies and data management solutions at Arab Health 2017 held in Dubai, United Arab Emirates.

ZOLL, an Asahi Kasei group company, develops and markets medical emergency care devices and software solutions, including products for defibrillation and monitoring, circulation and CPR feedback, data management, therapeutic temperature management, and ventilation. The Asahi Kasei group’s health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals and diagnostic reagents.

At the four-day event held from January 30 to February 2, 2017, at the Dubai International Convention & Exhibition Centre, ZOLL displayed new additions to its portfolio, including the ZOLL AED 3 automated external defibrillator and the ZOLL AED 3 BLS (basic life support). The ZOLL AED 3 BLS model is designed specifically for the needs of first responders with the CPR Dashboard and the ability to deliver the patient record directly to health care providers.

Additional resuscitation solutions from ZOLL on display at Arab Health 2017 included its small and lightweight X Series monitor/defibrillator, and the ResQCPR System, which is a combination of two medical devices, the CardioPump ACD-CPR device and the ResQPOD impedance threshold device (ITD). The devices are used together during CPR to create an enhanced vacuum in the chest that improves blood flow to the brain and vital organs.

Also on display at the event were ZOLL’s resuscitation solutions for the hospital environment, including its 731 family of portable ventilators, the AutoPulse Resuscitation System, an automated CPR device especially designed for use during transport of critically-ill patients, the R Series monitor/defibrillator, Intravascular Temperature Management (IVTM), which offers health care providers the precision and control they need to rapidly, safely, and effectively manage the core body temperature of critically-ill or surgical patients, and the Thermogard XP, a temperature management system that delivers accurate, easy-to-use, and cost-effective control for both cooling and warming applications.

Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
MRI System
nanoScan MRI 3T/7T
Radiation Safety Barrier
RayShield Intensi-Barrier

Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more